Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), PGRMC1 antagonists(Membrane-associated progesterone receptor component 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | - |